HappeningToo topic
Ipilimumab reports
Browse community reports connected to Ipilimumab. These reports can show that other people are describing similar experiences, but they do not prove that Ipilimumab caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
24 problems
Abdominal Pain while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and abdominal pain appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and back pain appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Chills while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and chills appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and constipation appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and cough appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and decreased appetite appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and dehydration appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and diarrhea appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and dizziness appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and fatigue appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and headache appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and hypotension appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and itching appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and malaise appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscular Weakness while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and muscular weakness appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and myalgia appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and nausea appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and pain appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash Maculo-papular while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and rash maculo-papular appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and rash appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and shortness of breath appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and vomiting appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and weakness appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Ipilimumab
FDA FAERS contains adverse-event reports in which Ipilimumab and weight decreased appear together. This does not establish that Ipilimumab caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →